Clinical Guideline for Pharmacological Management of Cancer Pain: The Japanese Society of Palliative Medicine Recommendations
Open Access
- 23 July 2013
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 43 (9), 896-909
- https://doi.org/10.1093/jjco/hyt099
Abstract
Pain is the most frequent and distressing symptom in cancer patients. As part of a worldwide effort to improve the quality of pain control, several clinical guidelines for the management of cancer pain have been published and revised in the last decade. The Japanese Society of Palliative Medicine first published a Japanese clinical guideline for the management of cancer pain in 2000. Since then, many clinical studies concerning cancer pain management have been conducted, new drugs have become available in Japan and the methodology of developing a guideline has been refined. Therefore, we decided to develop a novel clinical guideline. This review paper summarizes the recommendations and the rationales of this new clinical guideline for the pharmacological management of cancer pain. In addition, a short summary of the clinical guideline development process is provided. This new Japanese Society of Palliative Medicine guideline highlights the importance of conducting well-designed studies to identify the best practices in cancer pain management.Keywords
This publication has 62 references indexed in Scilit:
- Recent Developments in the Management of Cancer Pain in Japan: Education, Clinical Guidelines and Basic ResearchJapanese Journal of Clinical Oncology, 2012
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- Prevalence of undertreatment in cancer pain. A review of published literatureAnnals Of Oncology, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Intravenous Morphine for Breakthrough (Episodic-) Pain in an Acute Palliative Care Unit: A Confirmatory StudyJournal of Pain and Symptom Management, 2008
- Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough painBritish Journal of Cancer, 2007
- A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysisEuropean Journal Of Cancer, 2002
- Analgesic Effect of Intravenous Ketamine in Cancer Patients on Morphine TherapyJournal of Pain and Symptom Management, 2000
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer painJournal of Pain and Symptom Management, 1992